Free Trial

Sernova (TSE:SVA) Trading Down 4.3% - Should You Sell?

Sernova logo with Medical background

Sernova Corp. (TSE:SVA - Get Free Report) fell 4.3% during mid-day trading on Monday . The stock traded as low as C$0.22 and last traded at C$0.22. 99,485 shares changed hands during trading, a decline of 38% from the average session volume of 160,012 shares. The stock had previously closed at C$0.23.

Analysts Set New Price Targets

Several research firms have commented on SVA. Leede Financial decreased their price target on shares of Sernova from C$3.00 to C$1.50 and set a "speculative buy" rating for the company in a research report on Friday, September 13th. Ventum Cap Mkts raised shares of Sernova to a "strong-buy" rating in a research report on Thursday, September 12th. Finally, Ventum Financial dropped their target price on Sernova from C$3.00 to C$2.50 and set a "buy" rating on the stock in a research note on Friday, September 13th.

Check Out Our Latest Research Report on SVA

Sernova Stock Performance

The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of 16.55. The firm has a 50-day moving average price of C$0.24 and a two-hundred day moving average price of C$0.27. The firm has a market cap of C$71.57 million, a PE ratio of -1.69 and a beta of 1.35.

About Sernova

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

See Also

Should You Invest $1,000 in Sernova Right Now?

Before you consider Sernova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.

While Sernova currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines